The State of Autoimmunity 2016 — A Progress Report: Part 1 (re-posted from Tincture)

Applying Technology to Empower Patients. 2016’s trends gave us glimmers of towards crossing the autoimmune abyss and achieving the vision of individualized autoimmune care. What was the state of autoimmunity in 2016, that unforgettable year full of positive and negative…

Functional Medicine with Dr. Bland

Turning Autoimmune Dreams into Reality Being a Big Vision entrepreneur is a ride on an emotional rollercoaster. My vision is of a connected world of personalized care for autoimmune patients, using data and digital tools to reshape research, diagnosis, and…

Friend or Foe: The Microbiome Lifeline at TRICON

Sneak peak at what the microbiome can do for autoimmunity. We will be holding a short course on the microbiome it’s promises during Cambridge Healthtech Institute’s 23rd International Molecular Med Tri-Con on March 6, 2016 in San Francisco - The…

Zephyr Health: Variety and Visualization Creates Useful Information

The dimensions of Big Data can be summed up by The Four Vs: Volume, Variety, Velocity, and Veracity.    But however large or diverse one’s data, it can often be hard to find exactly what one needs. As a researcher,…

Patient Communities Come in Many Flavors

Each day there seems to be a new type of patient community popping up. A good place to start to learn about these new approaches is a “Report on the Use of Social Media to Prevent Behavioral Risk Factors Associated…

Using Big Data to Personalize the Healthcare Experience: Clinical Trials and Cancer

How Big Data is Changing Current Research Methodology: Cancer Cancer is the second leading cause of death in the United States. Current treatments are ineffective with over 75% of patients not responding to treatments, despite the $50 billion pharmaceutical companies…

The Role of Big Data Personalizing the Healthcare Experience: Genomics

  Genomics is making headlines in both academia and the celebrity world.  When genetic tests revealed that Angelina Jolie was predisposed to breast cancer, intense media cover ensued. Since then, genetic testing and genomics have been propelled to the front of…

(Part 3) The Data “Revolution” in Healthcare: Obstacles and Opportunities

Part Three: Election Day special: Regulatory Obstacles (continued from Part Two) By Ellen Martin Here is a 352-page description of US healthcare regulation as of 2006: Robert I. Field’s Health Care Regulation in America: Complexity, Confrontation, and Compromise. It is always mind…

(Part 2) The Data “Revolution” in Healthcare: Obstacles and Opportunities

Part Two: Healthcare Structural Issues (continued from Part One) By Ellen Martin First, let’s recognize the fundamental market disconnect between providers, patients and third-party payers like employers, insurance companies, and managed care. This detachment is a fundamental reason as to why…

0